198 related articles for article (PubMed ID: 7569287)
1. Effects of lactitol [correction of lactilol] on hepatic encephalopathy and plasma amino-acid imbalance.
Trovato GM; Catalano D; Carpinteri G; Runcio N; Mazzone O
Recenti Prog Med; 1995; 86(7-8):299-303. PubMed ID: 7569287
[TBL] [Abstract][Full Text] [Related]
2. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
[TBL] [Abstract][Full Text] [Related]
3. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
[TBL] [Abstract][Full Text] [Related]
4. Serum amino acids in hepatic encephalopathy--effects of branched chain amino acid infusion on serum aminogram.
Watanabe A; Takesue A; Higashi T; Nagashima N
Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):346-57. PubMed ID: 525213
[TBL] [Abstract][Full Text] [Related]
5. [1st use of lactitol in the treatment of porto-systemic encephalopathy].
Bircher J; Bührer M; Franz K; van Velthuijsen JA
Schweiz Med Wochenschr; 1982 Sep; 112(38):1306-7. PubMed ID: 7134954
[TBL] [Abstract][Full Text] [Related]
6. Plasma amino acid patterns in hepatic encephalopathy of differing etiology.
Rosen HM; Yoshimura N; Hodgman JM; Fischer JE
Gastroenterology; 1977 Mar; 72(3):483-7. PubMed ID: 832796
[TBL] [Abstract][Full Text] [Related]
7. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
Schmidt LE; Tofteng F; Strauss GI; Larsen FS
Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
[TBL] [Abstract][Full Text] [Related]
8. An approach to nutritional therapy of hepatic encephalopathy by normalization of deranged amino acid patterns in serum.
Watanabe A; Higashi T; Nagashima H
Acta Med Okayama; 1978 Dec; 32(6):427-40. PubMed ID: 154828
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
Bauer AG; Wilson JH; Lamberts SW; Blom W
Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
[TBL] [Abstract][Full Text] [Related]
10. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
[TBL] [Abstract][Full Text] [Related]
11. Plasma amino acids in hepatic encephalopathy.
Ferenci P; Wewalka F
J Neural Transm Suppl; 1978; (14):87-94. PubMed ID: 290744
[TBL] [Abstract][Full Text] [Related]
12. Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
Masini A; Efrati C; Merli M; Attili AF; Amodio P; Ceccanti M; Riggio O
Am J Gastroenterol; 1999 Nov; 94(11):3323-7. PubMed ID: 10566738
[TBL] [Abstract][Full Text] [Related]
13. Effects of keto analogues of essential amino acids in portal-systemic encephalopathy.
Maddrey WC; Weber FL; Coulter AW; Chura CM; Chapanis NP; Walser M
Gastroenterology; 1976 Aug; 71(2):190-5. PubMed ID: 939376
[TBL] [Abstract][Full Text] [Related]
14. [Lactilol (Importal, 10g in powder made by ZYMA) in the treatment of portal systemic encephalopathy].
Boca M; Duris I; Kolibás E; Kratochvíl'ová E
Vnitr Lek; 1996 Apr; 42(4):234-8. PubMed ID: 8693708
[TBL] [Abstract][Full Text] [Related]
15. Alteration in plasma amino acid concentrations following subtotal hepatectomy in dogs.
Nagasue N; Kanashima R; Inokuchi K
Ann Chir Gynaecol; 1981; 70(2):50-5. PubMed ID: 6797341
[TBL] [Abstract][Full Text] [Related]
16. [The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K; Suzuki K; Sato S
Nihon Yakurigaku Zasshi; 1995 May; 105(5):389-402. PubMed ID: 7628787
[TBL] [Abstract][Full Text] [Related]
17. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.
Knudsen GM; Schmidt J; Almdal T; Paulson OB; Vilstrup H
Hepatology; 1993 Jun; 17(6):987-92. PubMed ID: 8514271
[TBL] [Abstract][Full Text] [Related]
18. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
Fehér J; Prónai L
Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
[TBL] [Abstract][Full Text] [Related]
19. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients].
Grandi M; Sacchetti C; Pederzoli S; Celani MF
Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974
[TBL] [Abstract][Full Text] [Related]
20. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt.
Riggio O; Balducci G; Ariosto F; Merli M; Pieche U; Pinto G; Tremiterra S; Ziparo V; Capocaccia L
Dig Dis Sci; 1989 Jun; 34(6):823-9. PubMed ID: 2656134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
